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Ocular Perfusion Pressure and the Incidence of
Glaucoma: Real Effect or Artifact?: The Rotterdam Study
Wishal D. Ramdas,1,2 Roger C. W. Wolfs,1,2 Albert Hofman,1 Paulus T. V. M. de Jong,1,3,4
Johannes R. Vingerling,1,2 and Nomdo M. Jansonius1,5
PURPOSE. To determine the association between the ocular
perfusion pressure (OPP; essentially the difference between
the blood pressure and the intraocular pressure [IOP]) and
incident open-angle glaucoma (OAG).
METHODS. A subset of 3882 participants of the population-based
Rotterdam Study for whom data from ophthalmic examinations
at baseline and follow-up and blood pressure measurements at
baseline were available, and who did not have OAG at baseline,
were included. Associations between the mean, systolic and
diastolic OPP, and incident OAG were assessed using Cox
regression models adjusted for age and sex, with and without
adjustment for IOP.
RESULTS. During a mean follow-up of 9.8 years, 103 participants
(2.7%) developed OAG. The association between the mean
OPP and incident OAG was not significant (hazard ratio 0.995
per mm Hg increase in mean OPP; 95% confidence interval
0.971–1.019) when adjusted for IOP, but became significant if
not adjusted for IOP (0.968; 0.945–0.992). The systolic and
diastolic OPP showed a pattern similar to that of the mean
OPP, though less significant.
CONCLUSIONS. The OPP appears to be associated with incident
OAG but this association seems to be due to the fact that the
IOP, a strong risk factor for OAG, is part of the OPP, rather than
that OPP is an independent OAG risk factor itself. (Invest
Ophthalmol Vis Sci. 2011;52:6875–6881) DOI:10.1167/iovs.11-
7376
Open-angle glaucoma (OAG) is a neurodegenerative diseasethat causes progressive damage to the optic nerve head
and leads to visual field loss. Some of the risk factors for OAG
have been identified; the most obvious risk factor is an in-
creased intraocular pressure (IOP).1–3 It has been proposed
that vascular components are also involved in the pathophys-
iology of OAG.4–10 One of the first studies showing a possible
link between (systemic) blood pressure and OAG was done in
1911 in Germany.11 Thereafter, many researchers studied the
relationships between blood pressure and IOP and blood pres-
sure and OAG. Blood pressure appears to be associated with
the IOP; no unambiguous effect of blood pressure on OAG has
been found thus far.12–21
Blood pressure may affect the perfusion of the optic nerve
head by influencing the perfusion pressure and also, especially
in longstanding hypertension, by influencing the vessel diam-
eter.22 The actual perfusion of the optic nerve head can be
measured but these measurements are difficult to perform
reliably, especially on a large scale.23 For that reason, in epi-
demiologic studies, a proxy of the perfusion pressure is used
rather than a measurement of the actual perfusion of the optic
nerve head. In most tissues, the perfusion pressure equals
essentially the difference between the arterial and venous
blood pressure. In the eye, the actual mean ocular perfusion
pressure (mean OPP; MOPP) is commonly estimated by the
difference between the arterial blood pressure and the IOP
(defined more precisely in the Methods section).5,24
The relationship between the arterial blood pressure and
OAG is complicated. As explained above, blood pressure is
part of the MOPP, and a higher MOPP is presumed to decrease
the risk of OAG. On the contrary, an increased blood pressure
may reduce the vessel diameter and this might increase the risk
of OAG. It becomes even more complicated when the IOP is
taken into account as well. Because blood pressure is positively
associated with IOP, systemic hypertension indirectly in-
creases the risk of OAG. IOP is presumed to have a direct
mechanical effect on the axons of the ganglion cells, but is also
part of the MOPP—a higher IOP implies a lower MOPP. This
implies that MOPP could pop up as a risk factor for OAG solely
because IOP is part of it, and this might explain the contradict-
ing results regarding the relationship between MOPP and
OAG25–28: some studies adjusted their analyses for IOP,16,19,29
whereas others did not.13,17,18,30
The aim of this study was to clarify the intertwined relation-
ships between blood pressure, MOPP and IOP, and OAG.
Simply incorporating blood pressure, MOPP and IOP as three
independent variables in a single model with OAG as the
dependent variable is not informative. This is because, apart
from being mutual confounding factors, the variables may be
correlated too strongly (blood pressure and MOPP; IOP and
MOPP) and may form a causal pathway (for example, IOP
constitutes a causal pathway between blood pressure and
OAG). For that reason, we first analyzed the association be-
tween MOPP and OAG with adjustment for IOP. Next, we
From the Departments of 1Epidemiology and 2Ophthalmology,
Erasmus Medical Center, Rotterdam, The Netherlands; the 3Depart-
ment of Ophthalmogenetics, The Netherlands Institute for Neurosci-
ence, RNAAS, Amsterdam, The Netherlands; the 4Department of Oph-
thalmology, Academic Medical Center, Amsterdam, The Netherlands;
and the 5Department of Ophthalmology, University Medical Center
Groningen, University of Groningen, Groningen, The Netherlands.
Supported by Stichting Lijf en Leven, Krimpen aan de Lek; MD
Fonds, Utrecht; Rotterdamse Vereniging Blindenbelangen, Rotterdam;
Stichting Oogfonds Nederland, Utrecht; Blindenpenning, Amsterdam;
Blindenhulp, The Hague; Algemene Nederlandse Vereniging ter
Voorkoming van Blindheid (ANVVB), Doorn; Landelijke Stichting voor
Blinden en Slechtzienden, Utrecht; Swart van Essen, Rotterdam; Sticht-
ing Winckel-Sweep, Utrecht; Henkes Stichting, Rotterdam; Lame´ris
Ootech BV, Nieuwegein; Medical Workshop, de Meern; Topcon Eu-
rope BV, Capelle aan de IJssel, all in The Netherlands, and Heidelberg
Engineering, Dossenheim, Germany.
Submitted for publication February 11, 2011; revised April 16,
2011; accepted June 15, 2011.
Disclosure: W.D. Ramdas, None; R.C.W. Wolfs, None; A. Hof-
man, None; P.T.V.M. de Jong, None; J.R. Vingerling, None; N.M.
Jansonius, None
Corresponding author: Johannes R. Vingerling, Department of
Ophthalmology, and Department of Epidemiology, Erasmus Medical
Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Nether-
lands; j.vingerling@erasmusmc.nl.
Clinical and Epidemiologic Research
Investigative Ophthalmology & Visual Science, August 2011, Vol. 52, No. 9
Copyright 2011 The Association for Research in Vision and Ophthalmology, Inc. 6875
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/933460/ on 05/03/2018
repeated the analysis without adjustment for IOP. We further
explored the role of the IOP in the MOPP by replacing the
blood pressure value in the MOPP of each participant by a
randomly allocated blood pressure value of another participant
and comparing the associations between MOPP and OAG be-
fore and after this replacement. Other factors that might be
related to perfusion were also explored. Earlier studies re-
ported a decreasing prevalence of OAG with an increasing
diastolic OPP (DOPP).13,18 Therefore, we also assessed the
relationships between systolic OPP (SOPP) and OAG and
DOPP and OAG. Finally, we analyzed the association between
blood pressure and IOP.
METHODS
Participants
The present study was performed within the Rotterdam Study, a prospec-
tive population-based cohort study of residents aged 55 years and older
living in Ommoord, a district of Rotterdam, The Netherlands. The ratio-
nale and study design have been described elsewhere.31,32 All measure-
ments were conducted after the Medical Ethics Committee of the Erasmus
University had approved the study protocol and all participants had given
a written informed consent in accordance with the Declaration of Hel-
sinki. Baseline examination took place between 1991 and 1993; follow-up
examinations for OAGwere performed from 1997 to 1999 and from 2002
to 2006. The present study included only participants who completed at
least one follow-up examination, had no OAG at baseline, and who had
valid data on OAG, IOP, and blood pressure.
Ophthalmic Examination and Incident
Open-Angle Glaucoma
The ophthalmic examinations at baseline and follow-up included a
medical history, autorefraction (Topcon RM-A2000; Tokyo Optical Co.,
Tokyo, Japan), keratometry (Topcon OM-4 Ophthalmometer; Tokyo
Optical Co.), measurement of the best corrected visual acuity with
Early Treatment Diabetic Retinopathy Study (ETDRS) optotypes, Gold-
mann applanation tonometry (Haag-Streit AG, Bern, Switzerland; see
below), fundus photography of the posterior pole (Topcon TRC-50VT,
Tokyo Optical Co., Tokyo, Japan), simultaneous stereoscopic fundus
photography of the optic nerve head (Topcon ImageNet System, Top-
con TRC-SS2, Tokyo Optical Co.), imaging of the optic nerve head
(Heidelberg Retina Tomograph; Heidelberg Engineering, Dossenheim,
Germany), and visual field testing (Humphrey Field Analyzer II 740
[HFA]; Carl Zeiss, Oberkochen, Germany).
The IOP was measured at baseline and at every follow-up round
with Goldmann applanation tonometry after applying oxybuprocaine
0.4% eye drops and fluorescein from a paper strip. Three measure-
ments were taken on each eye and the median value of these three
measurements was recorded.33 In the analysis we used the highest
median IOP of both eyes.
The visual field of each eye was screened using a 52-point thresh-
old-related supra-threshold test that covered the central field with a
radius of 24°.34,35 Visual field loss was defined as nonresponse to a light
stimulus of 6 dB above a threshold-related estimate of the hill of vision
in at least three contiguous test points, or four including the blind spot.
In participants with reproducible abnormalities on supra-threshold
testing, Goldmann perimetry (Haag-Streit AG; baseline and first follow-
up)34 or full-threshold visual field 24 to 2 testing (second follow-up)36
was performed on both eyes. The classification process of the perim-
etry test results have been described before.34,36 In short, visual field
loss was considered to be glaucomatous visual field loss only if repro-
ducible and after excluding all other possible causes.
Participants were considered to have incident OAG if neither eye
had glaucomatous visual field loss at baseline and at least one eye
showed glaucomatous visual field loss at follow-up.36 Cases with a
history or signs of angle closure (gonioscopy was performed in all
identified cases) or secondary glaucoma were excluded.
Blood Pressure and Ocular Perfusion Pressure
Blood pressure was measured at baseline after the participant had been
seated for at least 5 minutes. Systolic blood pressure (SBP; first Korot-
koff phase) and diastolic blood pressure (DBP; fifth Korotkoff phase)
were measured twice on the right arm using a random-zero sphygmo-
manometer with a 14 38 cm cuff. Afterward, we calculated the mean
of the two SBP values and of the two DBP values.37 The mean arterial
blood pressure (MABP) was calculated according to MABP  DBP 
(SBP  DBP)/3, where SBP  DBP is the pulse pressure.38 The MOPP
was calculated according to MOPP  2
3
MABP  IOP.38 The SOPP and
DOPP were calculated by subtracting the IOP from the SBP and DBP,
respectively.
Potential Confounders
Other factors that might be related to perfusion are, following the
Hagen-Poiseuille law, factors that influence the blood rheology (viscos-
ity) or the vessel diameter (the diameter has a much a larger influence
than vessel length and is more subject to change). The hematocrit is
the major determinant of viscosity in the general population.7 Apart
from blood pressure and hypertension, the vessel diameter may be
influenced by smoking, diabetes mellitus, and serum cholesterol. For
smoking and diabetes, trained research assistants asked participants
about their smoking habits and if they had diabetes. Smoking was
analyzed using nominal categories: never, former, and current smok-
ers. Hematocrit and cholesterol levels were derived from blood sam-
ples taken at the research center. Serum cholesterol was quantified as
the ratio of the high-density lipoprotein-bound cholesterol (HDL-C) and
total cholesterol levels (HDL-C/cholesterol ratio). Another potential
confounder is the body mass index.39,40 Body mass index was calcu-
lated as body mass in kilograms divided by the square of the height in
meters. All potential confounders were determined at baseline.
Statistical Analysis
Differences in baseline characteristics were analyzed with independent
t-tests and 2 statistics. We used Cox proportional hazard regression to
calculate hazard ratios (HR) with corresponding 95% confidence inter-
vals (CI) to analyze whether subjects with a high MOPP had a lower
risk of developing OAG. The model fits were evaluated with C-statis-
tics. Follow-up duration was used as the time variable. For participants
without incident OAG, the follow-up duration was counted from the
baseline visit to the last visit with reliable perimetry. For incident OAG
cases, the follow-up was counted until the first visit in which glauco-
matous visual field loss was detected. The multivariate model was
created by first entering all covariates in the model. In the final
multivariate model we included MOPP, age, sex, and those covariates
reaching a significance of P  0.05 or less in the initial multivariate
model—except for IOP-lowering treatment (see Discussion). This final
model was built with and without adjustment for IOP.
MOPP and IOP together in a multivariate model might lead to
multicollinearity issues, because the IOP is part of the MOPP. To assess
whether multicollinearity played a role in our analysis of MOPP ad-
justed for IOP we calculated the Pearson correlation coefficient and
the variance inflation factor (VIF).
As mentioned in the introduction section, MOPP could pop up as
a risk factor for OAG solely because IOP is part of it. To assess whether
the blood pressure has an additional contribution to the significance of
MOPP as a risk factor for OAG, we further explored the role of the
MOPP by recalculating the MOPP after replacing the blood pressure
value of each participant by a randomly allocated blood pressure value
of another participant (sampling without replacement). Next, we re-
calculated the HR of the association between MOPP—without adjust-
ment for IOP—and OAG. This was repeated 30 times. The resulting 30
HRs were compared with that of the original model. The same ap-
proach was applied for SOPP and OAG and DOPP and OAG.
The relationships between SOPP and OAG and DOPP and OAG
were further explored by stratifying both SBP and DBP into five
categories each containing approximately 19 OAG cases. For each of
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the SBP pentiles, a Cox proportional hazard regression was performed
with SOPP as independent variable, and for each of the DBP pentiles,
this analysis was performed with DOPP as independent variable. This
was done with and without adjustment for IOP.
The relationship between blood pressure and IOP at baseline was
analyzed by performing multiple linear regression analyses with IOP as
the dependent variable and blood pressure, age, sex, treatment for
IOP, and treatment for hypertension as the independent variables. This
model was run for three different blood pressure variables: MABP, SBP,
and DBP.
A P-value of 0.05 or less was considered statistically significant. All
statistical analyses were performed using statistical analysis software
(SPSS version 15.0.0 for Windows; SPSS Inc., Chicago, IL; and R
statistical package version 2.9.1 for Mac; http://www.r-project.org).
RESULTS
The ophthalmic part of the Rotterdam Study comprised 6806
participants, of which 3939 had no OAG at baseline and par-
ticipated at least in one follow-up round. Of these, 57 partici-
pants were excluded because of missing data on blood pres-
sure or IOP. From the remaining participants, 103 out of 3882
(2.7%) developed OAG during follow-up.
Table 1 summarizes the baseline characteristics of the study
population according to incident OAG status. Compared with
participants without OAG, participants who developed OAG
during the study were significantly older (P  0.001), had
higher baseline IOP (P  0.001), and were more often treated
for IOP at baseline (P  0.001). None of the potential con-
founders (hematocrit, blood pressure, usage of antihyperten-
sive drugs, smoking, diabetes mellitus, HDL-C/cholesterol ra-
tio, and body mass index) showed significant differences
between participants without OAG and those who developed
OAG during follow-up. Body mass index was the only potential
confounder that was significant in the initial multivariate anal-
ysis. We did not incorporate this variable in the final models
because its presence did not change either the effect estimates
or the significances of the relevant variables (IOP, MOPP,
SOPP, and DOPP).
Table 2 presents the final multivariate models for MOPP
with and without adjustment for IOP. We could not find an
association between MOPP and incident OAG if adjusted for
IOP (HR: 0.995 per mm Hg increase in MOPP; 95% CI: 0.971–
1.019), but the association became significant after we re-
moved IOP from the model (HR: 0.968; 95% CI: 0.945–0.992).
The C-statistics of the models with and without adjustment for
IOP were 0.70 and 0.67, respectively. The Pearson correlation
coefficient of MOPP and IOP was 0.227 (P  0.001). The
resulting variance inflation factor of 1.054 suggests that multi-
collinearity had no significant effect.
The role of adjusting for IOP or not, and thus the contribu-
tion of IOP to MOPP, was further assessed with the resampling
technique as described in the Methods section. Figure 1A
shows the results. The HRs of the resampled MOPP data scat-
tered around the HR of the original dataset (solid line in Fig.
1A), indicating that the significance of the MOPP in a model
without adjustment for IOP is essentially due to the fact that
the IOP is part of the MOPP. Next, we investigated whether
this finding could be explained by the fact that both the SBP
and the DBP were taken together in the formula for computing
the MOPP variable. If only one of these variables would con-
tribute significantly, the statistical noise added by the other
variable could have masked the effect. Models with SOPP and
DOPP instead of MOPP revealed, with adjustment for IOP, a HR
of 0.998 (95% CI, 0.987–1.008) for SOPP and a HR of 0.997
(95% CI, 0.978–1.016) for DOPP. The same models without
adjustment for IOP yielded a HR of 0.994 (95% CI, 0.984–
1.005) for SOPP and a HR of 0.980 (95% CI, 0.961–0.999) for
DOPP. Figures 1B and 1C show the corresponding results of
the resampling technique applied to the SOPP (Fig. 1B) and
DOPP (Fig. 1C) data, respectively. Again, there was no clear
difference between the original HRs (solid lines in Fig. 1B and
TABLE 1. Baseline Characteristics of the Study Population with and without Incident
Open-Angle Glaucoma
Incident Open-Angle
Glaucoma (n  103)
No Open-Angle
Glaucoma (n  3779) P
Age, y 67.8  7.0 65.2  6.8 0.001
Sex, n (%) female 51 (49.5) 2221 (58.8) 0.060
IOP, mm Hg 18.2  4.7 16.0  3.1 0.001
Treatment for IOP, n (%) 16 (15.5) 85 (2.2) 0.001
Hematocrit Level (100) 42.1  3.0 41.5  3.2 0.089
Systolic blood pressure, mm Hg 136.9  21.0 135.7  20.7 0.587
Diastolic blood pressure, mm Hg 73.2  12.7 73.6  10.8 0.721
Antihypertensives, n (%) 28 (27.5) 976 (25.8) 0.715
Smoking, n (%) 0.526
Never 33 (32.0) 1256 (33.5)
Former 52 (50.5) 1698 (45.3)
Current 18 (17.5) 791 (21.1)
Diabetes mellitus, n (%) 7 (6.8) 142 (3.8) 0.120
HDL-C/cholesterol ratio 0.21  0.06 0.21  0.06 0.695
Body mass index 25.7  2.9 26.3  3.5 0.075
Data are presented as mean  standard deviation unless stated otherwise with univariate compari-
sons; 324 participants had missing data on one or more covariates.
TABLE 2. Multivariate Cox Proportional Hazard Model for Mean






With adjustment for IOP
Age, y 1.074 1.043–1.105 0.001
Sex, female 0.594 0.393–0.898 0.014
IOP, mm Hg 1.168 1.114–1.224 0.001
MOPP, mm Hg 0.995 0.971–1.019 0.675
Without adjustment for IOP
Age, y 1.080 1.050–1.112 0.001
Sex, female 0.554 0.368–0.834 0.005
MOPP, mm Hg 0.968 0.945–0.992 0.010
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1C) and that of the resampled datasets, neither for SOPP nor
for DOPP.
Figure 2 presents the relationships between SOPP and inci-
dent OAG and DOPP and incident OAG stratified for SBP and
DBP, for models with and without adjustment for IOP. There
were no clear associations with incident OAG, except for
DOPP without adjustment for IOP, especially in subjects with
lower DBP values (Fig. 2D).
Finally, we assessed the relationships between IOP and the
blood pressure variables MABP, SBP, and DBP. IOP was
strongly associated with all three variables (P  0.001). The
corresponding regression coefficients were 0.035, 0.025, and
0.029 mm Hg increase in IOP per mm Hg increase in MABP,
SBP, and DBP, respectively. The percentages of variance in IOP
explained by the MABP, SBP, and DBP (R2) were 2.0%, 2.5%,
and 1.0%, respectively.
DISCUSSION
The MOPP appeared not to be an independent risk factor for
OAG. Models without adjustment for IOP suggested a protec-
tive effect of a higher MOPP. This finding, however, could be
explained by the fact that the IOP is part of the MOPP. A
similar—albeit less obvious—protective effect was found for
DOPP, but not for SOPP. This difference is most likely caused
by the smaller SD of the DBP compared with that of the SBP
(Table 1). A smaller SD in a blood pressure variable results in a
FIGURE 1. Hazard ratios and corre-
sponding 95% CI for the resampled
datasets of the associations between
MOPP and open-angle glaucoma (A),
SOPP and open-angle glaucoma (B),
and DOPP and open-angle glaucoma
(C). In the resampled datasets, the
blood pressure value of each partici-
pant was replaced by a randomly allo-
cated blood pressure value of another
participant. Solid line represents the
HR of the original dataset; dotted lines
the corresponding 95% CI.
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larger contribution to the variability of the corresponding OPP
variable explained by the IOP. This hypothesis is further sup-
ported by the finding that the highest DBP pentile had the
highest SD and the least significant DOPP (Fig. 2D). The blood
pressure variables were significantly associated with the IOP,
but the variance of IOP explained by these variables was low,
suggesting a minor importance in the pathophysiology of OAG
(a 40 mm Hg change in SBP, for example, corresponded to a 1
mm Hg change in IOP).
Studies describing the possible association between MOPP
and OAG used models with different covariates, making it
difficult to compare results between these (epidemiologic)
studies. Obviously, the most important covariate in this asso-
ciation is the IOP. Studies in which OPP was adjusted for IOP,
The Barbados Eye Study,15 The Early Manifest Glaucoma
Trial,27 and The Blue Mountain Eye Study,19 could not find a
significant association between MOPP and OAG. The Blue
Mountains Eye Study found a modest increase in risk of OAG in
participants with hypertension, especially in those who were
poorly controlled. They also evaluated the potential relation-
ship of OPP with OAG and OPP with ocular hypertension (the
latter not adjusted for IOP). The relationship of OPP with OAG
was significant for neither MOPP nor DOPP, but a marginal
significance was found for SOPP with OAG (P  0.05). For the
relationship between OPP and ocular hypertension they found
that only DOPP had a protective effect (P  0.0008).19 Studies
in which OPP was not adjusted for IOP, The Baltimore Eye
Survey,18 The Egna-Neumarkt Study,17 Proyecto VER,30 and
previously our Rotterdam Study (but limited to persons receiv-
ing antihypertensive medications),13 found a reduced DOPP to
be a risk factor for OAG. Hence, most studies reporting a low
OPP as a risk factor for OAG were not adjusted for IOP—as was
our approach in Table 2B, and most studies that failed to find
an association between OPP and OAG were adjusted for
IOP—as was our approach in Table 2A.41
Apart from possible limitations in the way MOPP is calcu-
lated from brachial artery measurements,42 the most obvious
limitation of epidemiologic studies is the fact that measure-
ments are performed only once and only during daytime. In
this way, any circadian influence on blood pressure or IOP will
be overlooked, as will be the influence of any other fluctuation.
It has been suggested that fluctuations in IOP are more dam-
aging to the optic disc than an increase in IOP.43–45 In addi-
tion, another study suggested that patients with progression of
OAG despite a normalized IOP suffer from insufficient autoreg-
ulation due to vascular dysregulation.46 One study, evaluating
the diurnal fluctuations (between 7 AM and 10 PM) of IOP and
MOPP in participants with and without OAG, reported that
patients with OAG do not have significant diurnal changes in
IOP, but they observed significant fluctuations in the MOPP.38
The range of diurnal fluctuations in IOP may be narrowed by
IOP-lowering treatment and might be captured by analyzing
large numbers of participants examined during the day. How-
ever, less is known about what happens during the night.47
Patients suffering from unstable blood flow, due to vascular
dysregulation, may be unable to compensate for physiologic
fluctuations in IOP and blood pressure to maintain MOPP.48
Besides, nocturnal dipping of blood pressure and circadian
fluctuations in OPP are associated with the development and
progression of OAG,49 which is probably due to vascular dys-
regulation resulting in ischemia.28,50 Related to this, serum
concentrations of endothelin-1 (vasoconstrictor) have been
found to be slightly increased in patients with progressing
glaucomatous visual field loss despite normal IOP.28
Almost all participants in the Rotterdam Study are from
European descent. Differences in properties of vascular factors
(such as hypertension) across populations of different ethnici-
ties have been described,51 and as a consequence findings on
OPP might differ between populations.
The effect of IOP-lowering treatment was not taken into
account in the main analyses of the present study—albeit
significant in the univariate comparison (Table 1). Unlike the
other covariates in Table 1, the IOP-lowering treatment is not
in a potential physiological pathway affecting the risk of devel-
oping OAG. Moreover, this covariate is highly correlated with
the IOP and the risk of developing OAG. It reflects the clini-
cian’s concern about the risk of glaucoma that may take into
consideration for example the appearance of the optic disc and
the family history. Nonetheless, if we would add the variable
for IOP-lowering treatment to the analyses, the results did not
alter significantly. Some antihypertensive drugs (e.g., calcium
channel blockers) have been implicated in OAG.52,53 The cur-
rent analyses evaluating the relationship between OPP and
OAG were not adjusted for the usage of antihypertensive drugs
(because the corresponding P-value was above 0.05 in the
initial multivariate analysis). Re-entering either the usage of any
antihypertensive drugs in the model or adding the usage of
calcium channel blockers to the model did not change either
FIGURE 2. Hazard ratios and corresponding 95% CI of the associations between systolic ocular perfusion pressure and open-angle glaucoma, as
a function of the systolic blood pressure (A, B), and between diastolic ocular perfusion pressure and open-angle glaucoma, as a function of the
diastolic blood pressure. Analyses adjusted for age and sex with (A, C) and without (B, D) adjustment for the IOP.
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the effects estimates or the significances of the relevant vari-
ables (IOP, MOPP, SOPP, and DOPP; data not shown). The
results on the relationship between MABP, SBP, and DBP and
IOP were adjusted for the usage of antihypertensive drugs. The
removal of this covariate did not change the findings. The body
mass index was the only possible confounder that was signif-
icant in the initial multivariate model, but its presence in the
model did not have any influence on either the IOP or the OPP
variables (see Results section). Other factors such as smoking,
diabetes mellitus, and cholesterol levels, are known to affect
the vascular wall thickness through atherosclerosis. However,
none of these factors was significant in the initial multivariate
model. In an earlier study, we did not find an association
between atherosclerosis and OAG.54 In agreement with this, it
has been suggested that it is not atherosclerosis but vascular
dysregulation and insufficient autoregulation that leads to a
low OPP (see also above).6,55
In conclusion, we found no independent significant effect
of OPP on the development of OAG. The current findings
suggest that, in epidemiologic studies, the observed association
between OPP and OAG is essentially due to the fact that the
IOP is part of the OPP.
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